Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cryoport, Inc. Director's Dealing 2022

May 4, 2022

32876_dirs_2022-05-03_7e430cde-ef33-4e5c-ace0-fcfeff7c1218.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cryoport, Inc. (CYRX)
CIK: 0001124524
Period of Report: 2022-04-29

Reporting Person: BADDOUR LINDA (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-04-29 Common Stock A 7203 Acquired 8655 Direct
2022-04-30 Common Stock M 2708 Acquired 11363 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-04-30 Restricted Stock Rights $ M 2708 Disposed Common Stock (2708) Direct
2022-04-29 Option (Right to Buy Common Stock) $22.56 A 13981 Acquired 2029-04-29 Common Stock (13981) Direct

Footnotes

F1: Reflects grant of restricted stock rights that vest in full on April 29, 2023, and upon vesting automatically convert to shares of common stock on a one-for-one basis.

F2: Restricted stock rights convert to common stock upon vesting on a one-for-one basis and have no expiration date.

F3: 1/12th of the options vest on the 30th of the month for twelve months beginning May 30, 2022.